Clinical Trials Directory

Trials / Completed

CompletedNCT03777098

Pilot Study of Strepic® Device for the Diagnosis of Group A Streptococcal Pharyngitis

Status
Completed
Phase
Study type
Observational
Enrollment
426 (actual)
Sponsor
David A. Talan · Academic / Other
Sex
All
Age
7 Years – 64 Years
Healthy volunteers
Not accepted

Summary

The objective of this pilot study is to acquire images using the Strepic® device, a clinical prototype that has been designed specifically as a viable, low-cost, commercially realizable autofluorescence-based diagnostic test, using (1) fluorescence and (2) white light image data, as well as other clinical data points. By acquiring and analyzing the images of pharyngeal bacterial fluorescence and white light patterns in patients with Group A Streptococcus (GAS)-associated pharyngitis and comparing them with those observed in non-GAS pharyngitis, it is believed an algorithm can be developed such that the device will improve the ability of clinicians to quickly and accurately identify GAS infections.

Conditions

Interventions

TypeNameDescription
DEVICEStrepic® DeviceThe Strepic® device is a qualitative point-of-care diagnostic test for the detection of GAS pharyngitis. The test uses direct visualization of the pharynx with a light source of specified wavelengths, causing excitation of endogenous fluorophores that emit a characteristic colored light pattern. White light images may give additional diagnostic accuracy through use of an artificial intelligence analysis of a large set of images of GAS and non-GAS pharyngitis.

Timeline

Start date
2019-01-02
Primary completion
2021-11-30
Completion
2021-12-30
First posted
2018-12-17
Last updated
2022-04-20

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03777098. Inclusion in this directory is not an endorsement.